Chinese Drug Company Sued Over Valsartan With Potential Carcinogen

Mealey's (August 24, 2018, 9:09 AM EDT) -- NEW YORK — A class action was filed Aug. 16 in New York federal court against the manufacturers and retailers of a blood pressure/heart failure drug that allegedly contains a potential...
To view the full article, register now.